InsiderTrades

Form 4 for AXGN Axogen, Inc.

Accepted 2024-06-10 00:00:00 ET · period of report 2024-06-06 · accession 0000805928-24-000099 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-06-10 2024-06-06 AXGN JOHNSON JOHN Dir A - Grant — +10.7K 17.1K +165% —
D 2024-06-10 2024-06-06 AXGN JOHNSON JOHN Dir A - Grant $0.00 +18.2K 18.2K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-06 A A 10,653 — 17,112 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
2 Derivative Employee Stock Option (right to purchase) 2024-06-06 A A 18,248 $0.00 18,248 D $7.04 · — to 2034-06-06 18,248 Common Stock (F2) Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 6, 2025, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.